Literature DB >> 1379854

Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.

C F Perno1, D A Cooney, W Y Gao, Z Hao, D G Johns, A Foli, N R Hartman, R Caliò, S Broder, R Yarchoan.   

Abstract

Cells of the monocyte lineage are important targets for the replication of human immunodeficiency virus (HIV). Our group and others have previously shown that granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates HIV replication in monocyte/macrophages, but that it also enhances the anti-HIV activity of 2',3'-dideoxy-3'-azidothymidine (AZT). In the present study, we have explored the effects of other bone marrow stimulatory cytokines on the replication of HIV and on the anti-HIV activity of certain dideoxynucleosides in human peripheral blood monocyte/macrophages (M/M). Like GM-CSF, macrophage CSF (M-CSF) enhanced HIV replication in M/M. In contrast, granulocyte CSF (G-CSF) and erythropoietin (Epo) had no such effects. The anti-HIV activity of zidovudine (AZT) was increased in M/M exposed to GM-CSF. In contrast, the anti-HIV activity of AZT was unchanged in M/M exposed to M-CSF, and the activities of 2',3'-dideoxycytidine (ddC) and 2',3'-dideoxyinosine (ddl) were unchanged or slightly diminished in M/M stimulated with GM-CSF or M-CSF. These differential activities of AZT and ddC were paralleled by differential effects of the cytokines on the anabolism of these drugs to their active 5'-triphosphate moieties. GM-CSF increased the levels of AZT-5'-triphosphate (at least in part through an increase in thymidine kinase activity) and overall induced an increase in the ratio of AZT-5'-triphosphate/thymidine-5'-triphosphate. In contrast, M-CSF-induced increases in AZT-5'-triphosphate were roughly matched by increases in thymidine-5'-triphosphate. Also, GM-CSF- or M-CSF-induced increases in the levels of ddC-5'-triphosphate were associated with parallel increases in the levels of deoxycytidine-5'-triphosphate (the physiologic nucleoside that competes at the level of reverse transcriptase), so that there was relatively little net change in the ddC-5'-triphosphate/deoxycytidine-5'-triphosphate ratio. Thus, bone marrow stimulatory cytokines may have a variety of effects on HIV replication and on the activity and metabolism of dideoxynucleosides in M/M.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379854

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection.

Authors:  J C Adkins; D H Peters; D Faulds
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

2.  Current Management of AIDS Related Non Hodgkin's Lymphoma.

Authors:  Kathryn Fife; Mark Bower
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  Granulocyte macrophage colony stimulating factor is elevated in alveolar macrophages from sheep naturally infected with maedi-visna virus and stimulates maedi-visna virus replication in macrophages in vitro.

Authors:  Z Zhang; G D Harkiss; J Hopkins; C J Woodall
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

4.  Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

Authors:  E L Jacobson; F Pilaro; K A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 5.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

Review 6.  Antiretroviral pharmacology in mucosal tissues.

Authors:  Corbin G Thompson; Myron S Cohen; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

7.  Interleukin-2 inhibits HIV-1 replication in some human T cell lymphotrophic virus-1-infected cell lines via the induction and incorporation of APOBEC3G into the virion.

Authors:  Raphael M Oguariri; Lue Dai; Joseph W Adelsberger; Adam Rupert; Randy Stevens; Jun Yang; Dawei Huang; Richard A Lempicki; Ming Zhou; Michael W Baseler; H Clifford Lane; Tomozumi Imamichi
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

8.  Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.

Authors:  David J Mock; Joseph A Hollenbaugh; Waaqo Daddacha; Michael G Overstreet; Chris A Lazarski; Deborah J Fowell; Baek Kim
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

9.  Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.

Authors:  Pierre Antoine Brown; Jonathan B Angel
Journal:  J Immune Based Ther Vaccines       Date:  2005-05-18

10.  Adenosine Deaminase as a Biomarker of Tenofovir Mediated Inflammation in Naïve HIV Patients.

Authors:  Francisco Miguel Conesa-Buendía; Patricia Llamas-Granda; Patricia Atencio; Alfonso Cabello; Miguel Górgolas; Raquel Largo; Gabriel Herrero-Beaumont; Aránzazu Mediero
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.